Luayon, Vilma .

HRN: 21-73-78  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
CEFUROXIME 1.5GM (VIAL)
08/10/2022
08/10/2022
IVT
1.5g
Single Dose
For EL
Waiting Final Action 
08/10/2022
CEFUROXIME 1.5GM (VIAL)
08/10/2022
08/16/2022
IV
1.5g
Q8hours
S/P Pelvic Lap
Waiting Final Action 
08/12/2022
CEFUROXIME 500MG (TAB)
08/12/2022
08/16/2022
PO
500mg Tab
BID
S/P Exploratory Laparotomy; Appendectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: